anti-Septin 9 (SEPT9) Antibodies

SEPT9 is a member of the septin family involved in cytokinesis and cell cycle control. Additionally we are shipping Septin 9 Proteins (7) and Septin 9 Kits (1) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
SEPT9 10801 Q9UHD8
SEPT9 53860 Q80UG5
SEPT9 83788 Q9QZR6
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top anti-Septin 9 Antibodies at

Showing 10 out of 41 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Delivery Price Details
Cow Rabbit Un-conjugated WB WB Suggested Anti-SEPT9(septin 9) Antibody Titration: 0.2-1 ug/mlPositive Control: HepG2 cell lysate 100 μL 2 to 3 Days
Cow Rabbit Un-conjugated IHC, WB Rabbit Anti-SEPT-9 Antibody Catalog Number: ARP51756_P050 Formalin Fixed Paraffin Embedded Tissue: Human heart Tissue Observed Staining: Cytoplasmic Primary Antibody Concentration: 1:100 Other Working Concentrations: N/A Secondary Antibody: Donkey anti-Rabbit-Cy3 Secondary Antibody Concentration: 1:200 Magnification: 20X Exposure Time: 0.5 - 2.0 sec WB Suggested Anti-SEPT9 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:62500 Positive Control: HCT15 cell lysate 100 μL 2 to 3 Days
Chicken Rabbit Un-conjugated IHC, IHC (p), WB 100 μL 11 to 14 Days
Human Rabbit Un-conjugated FACS, IHC (p), WB Western blot analysis of lysates from A431, Hela cell line (from left to right), using SEPT9 Antibody at 1:1000 at each lane. Western blot analysis of lysates from human kidney and liver tissue lysate (from left to right), using SEPT9 Antibody at 1:1000 at each lane. 400 μL 2 to 3 Days
Human Rabbit Un-conjugated WB Western blot analysis of extract of various cells, using 9-九月 antibody. 100 μL 11 to 13 Days
Human Rabbit Un-conjugated ELISA, WB 100 μL 2 to 3 Days
Human Rabbit Un-conjugated WB Septin 9 antibody used at 1 ug/ml to detect target protein. 50 μg 9 to 11 Days
Human Rabbit Un-conjugated WB Septin 9 antibody used at 0.5 ug/ml to detect target protein. 50 μg 9 to 11 Days
Human Mouse Un-conjugated ELISA, WB SEPT9 polyclonal antibody (A01), Lot # ABNOVA060629QCS1 Western Blot analysis of SEPT9 expression in PC-12 . Western Blot detection against Immunogen (37 KDa) . 50 μL 11 to 12 Days
Human Mouse Un-conjugated WB Western Blot analysis of SEPT9 expression in transfected 293T cell line by SEPT9 MaxPab polyclonal antibody.Lane 1: SEPT9 transfected lysate(62.48 KDa).Lane 2: Non-transfected lysate. SEPT9 MaxPab polyclonal antibody. Western Blot analysis of SEPT9 expression in HepG2. 50 μg 11 to 12 Days

Top referenced anti-Septin 9 Antibodies

  1. Human Polyclonal SEPT9 Primary Antibody for IHC (p), ELISA - ABIN545723 : Osaka, Rowley, Zeleznik-Le: MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). in Proceedings of the National Academy of Sciences of the United States of America 1999 (PubMed)
    Show all 5 Pubmed References

  2. Cow (Bovine) Polyclonal SEPT9 Primary Antibody for WB - ABIN2784607 : Sudo, Ito, Iwamoto, Morishita, Asano, Nagata: SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling. in Human mutation 2007 (PubMed)

  3. Human Polyclonal SEPT9 Primary Antibody for ELISA, WB - ABIN564709 : Tóth, Galamb, Spisák, Wichmann, Sipos, Valcz, Leiszter, Molnár, Tulassay: The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. in Pathology oncology research : POR 2011 (PubMed)

More Antibodies against Septin 9 Interaction Partners

Human Septin 9 (SEPT9) interaction partners

  1. The authors propose that septins in general and SEPT9 in particular play a previously unappreciated role in osteoclastic bone resorption.

  2. SEPT9 DNA methylation was detected in untreated colorectal carcinomas but not in adenomas.

  3. Study indicated that peripheral SEPT9 methylated DNA may be useful for the screening, early diagnosis, and recurrence monitoring of colorectal cancer.

  4. The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors.

  5. mSEPT9 is effective for colorectal cancer postsurgical assessment and prognosis prediction.

  6. Post-therapeutic SHOX2 and SEPT9 circulating cell-free DNA(ccfDNA) methylation levels correlated with UICC stage (all P <0.01). SEPT9 ccfDNA methylation further allowed for an accurate pre- and post-therapeutic detection of distant metastases.

  7. Thus our data indicate that Sept9_i2 is a negative regulator of breast tumorigenesis. We propose that Sept9 tumorigenic properties depend on the balance between Sept9_i1 and Sept9_i2 expression levels.

  8. The plasma levels of septin-9 and clusterin in ovarian cancer patients were abnormally elevated, which might be used as potential candidates of peripheral blood tumor biomarkers for early diagnosis of EOC and septin-9 might be related to distal metastases of EOC.

  9. The primary aim of this study was to evaluate the diagnostic accuracy of a PCR-based assay for the analysis of SEPT9 promoter methylation in circulating cell-free DNA (mSEPT9) for diagnosing hepatocellular carcinoma.

  10. Septin 9 regulates lipid droplet growth through binding to phosphatidylinositol-5-phosphate in Hepatitis C virus infected cells.Septin 9 regulates lipid droplets growth and perinuclear accumulation in a manner dependent on dynamic microtubules.Septin 9 regulates Hepatitis C virus replication.

  11. The SEPT9 assay exhibited satisfactory performance in colorectal cancer diagnosis and screening, while more evidence is needed for therapeutic effect monitoring and prognosis prediction.

  12. Studies indicate that methylated Septin 9 ((m)SEPT9) can be consistently detected in plasma samples derived from whole blood samples collected with S-Monovette(R) K3E and BD Vacutainer (R) K2EDTA tubes stored at 2-8 degrees C for a maximum of 24 h and for samples collected in S-Monovette CPDA tubes stored at 18-25 degrees C for up to 48 h.

  13. our study has validated a new SEPT9 assay and combined testing as an aid in cancer detection, providing a new approach for opportunistic CRC screening.

  14. Study shows a stepwise increase of SEPT9 methylation from non-cancerous to cancerous tissue in colorectal adenocarcinoma.

  15. Study found SHOX2 and SEPT9 frequently methylated in biliary tract cancers.

  16. These results indicate that SEPT9_v2 promoter hypermethylation, which silences the expression of SEPT9_v2 mRNA, is observed in a significant proportion of breast tumors, and that methylated SEPT9_v2 may serve as a novel tumor marker for breast cancer.

  17. The first evidence of an interaction between septins and a nonmitotic kinesin is provided and it is suggested that SEPT9 modulates the interactions of KIF17 with membrane cargo.

  18. SEPT9 promoter methylation and MN frequency, both measured in peripheral blood, occur at an early stage compared to carcinoma development, indicating that the approach might be suitable to monitor CRC development.

  19. KRAS mutations and SEPT9 promoter methylation were present in 34% (29/85) and in 82% (70/85) of primary tumor tissue samples.

  20. SEPT9_i1 is expressed in high-grade prostate tumors suggesting it has a significant role in prostate tumorigenesis.

Mouse (Murine) Septin 9 (SEPT9) interaction partners

  1. observations suggested that Sept9 contributed to alleviate liver fibrosis might partially through promoting activated HSCs apoptosis and this anti-fibrogenesis effect might be blocked by DNMT-3a mediated methylation of Sept9

  2. The altered T-cell homeostasis caused by the loss of Sept9 results in an increase of CD8(+) central memory T-cells.

  3. SEPT9 gene amplification and overexpression during mouse breast tumorigenesis

  4. Data reveal the importance of Sept9 for septin filament formation and general cell stability.

Zebrafish Septin 9 (SEPT9) interaction partners

  1. Zebrafish possess two genes, sept9a and sept9b that, like humans, express multiple transcripts.

Septin 9 (SEPT9) Antigen Profile

Protein Summary

This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.

Gene names and symbols associated with anti-Septin 9 (SEPT9) Antibodies

  • septin 9 (SEPT9) antibody
  • septin 9 (sept9) antibody
  • septin-9 (LOC100605286) antibody
  • septin 9 S homeolog (sept9.S) antibody
  • septin 9 (Sept9) antibody
  • septin 9a (sept9a) antibody
  • AF17q25 antibody
  • cb999 antibody
  • Eseptin antibody
  • fb02h06 antibody
  • Msf antibody
  • MSF1 antibody
  • NAPB antibody
  • PNUTL4 antibody
  • sept9 antibody
  • SeptD1 antibody
  • septin-9 antibody
  • Sint1 antibody
  • Slpa antibody
  • wu:fb02h06 antibody

Protein level used designations for anti-Septin 9 (SEPT9) Antibodies

septin 9 , septin-9-like , septin-9 , MLL septin-like fusion protein MSF-A , Ov/Br septin , ovarian/breast septin , septin D1 , MLL septin-like fusion , SL3-3 integration site 1 protein , E-septin , SLP , eighth septin , septin-like protein

483339 Canis lupus familiaris
733881 Xenopus (Silurana) tropicalis
100031227 Monodelphis domestica
100058313 Equus caballus
100140583 Bos taurus
100412361 Callithrix jacchus
100605286 Nomascus leucogenys
735161 Xenopus laevis
417347 Gallus gallus
10801 Homo sapiens
53860 Mus musculus
83788 Rattus norvegicus
337243 Danio rerio
Selected quality suppliers for anti-Septin 9 (SEPT9) Antibodies
Did you look for something else?